Sign in to view content

Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD

Szilárd Kiss, MD

Video
Published 2016

Related

Six Monthly Intravitreal Aflibercept to Improve Macular Perfusion in Diabetic Retinopathy Without Macular Edema
Yoon Jeon Kim, MD
Annual Meeting Talks
2023
Pyron Award, Permanent Keratoprosthesis and Complex Ocular Reconstruction: New Opportunities and Challenges for the Vitreoretinal Surgeon
Donald J. D'Amico, MD
Annual Meeting Talks
2016
Retina PractiCare: Coding Benchmarks for Retina Specialists
John T. Thompson, MD
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more